“Rifampicin in cutaneous leishmaniasis – a therapeutic trial in Saudi Arabia”, J Pak Assoc Dermatol, vol. 16, no. 1, pp. 4–9, Jan. 2017, doi: 10.66344/jpad.16.1.2006.838.